Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
C-MER Medical Holdings Limited (3309.HK)
HKD0.97
+0.04 (+4.30%)
HK HKSE Healthcare Medical - Care Facilities
Address
Central Building
Central, HK
Central, HK
CEO
Xiaoting Li
Website
cmermedical.com
IPO
2018-01-15
ISIN KYG2R51A1053
Description
C-MER Medical Holdings Limited specializes in offering both medical treatments and therapeutic services for a variety of eye conditions. Its business activities are segmented into two primary areas: the delivery of ophthalmological services and the retail of vision-enhancing products. Established by Shun Chiu Lam on February 1, 2016, the organization's corporate headquarters are situated in Hong Kong.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
HKD0.97
+0.04 (+4.30%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
317.9K
Beta
0.44
Float Shares
508.78M
Free Float %
42.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.92% | -1.85% | -13.82% | -28.38% | -39.08% | -38.37% | -37.65% | -73.16% | -83.17% | -79.26% | -79.26% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.97
DCF (Unlevered)
6.81
+601.9%
DCF (Levered)
5.99
+517.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.77
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+1.8% Q4'25: +2.9% (vs Q4'23)
-
EPS growth Medical - Care Facilities: +19.2%+175.7% ★ Q4'25: +63.8% (vs Q4'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+2.2% Q4'25: +14.5% (vs Q4'23)
-
EBIT margin Medical - Care Facilities: +11.3%+7.3% Q4'25: +7.6% (vs Q4'23)
-
ROIC Medical - Care Facilities: +6.8%+5.4% Q4'25: +11.0% (vs Q4'23)
-
Share dilution Medical - Care Facilities: +0.0%-2.3% ★ Q4'25: -4.4% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.07× ★ Q4'25: 1.00× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
311.23M
est: 291.00M (+7.0%)
|
429.37M
est: 468.00M (-8.3%)
|
576.21M
est: 291.00M (+98.0%)
|
699.55M
est: 468.00M (+49.5%)
|
1.11B
est: 536.00M (+107.6%)
|
1.73B
est: 683.00M (+153.6%)
|
1.92B
est: 1.90B (+1.5%)
|
1.91B
est: 2.19B (-12.6%)
|
1.95B
est: 2.46B (-20.9%)
|
2.08B
2.08B – 2.08B
-15.4% YoY
|
2.23B
2.23B – 2.23B
+7.4% YoY
|
2.40B
2.40B – 2.40B
+7.3% YoY
|
| EBITDA |
90.69M
est: 42.45M (+113.6%)
|
84.39M
est: 68.28M (+23.6%)
|
139.47M
est: 42.45M (+228.5%)
|
111.39M
est: 68.28M (+63.1%)
|
177.80M
est: 78.20M (+127.4%)
|
194.31M
est: 99.64M (+95.0%)
|
363.38M
est: 256.48M (+41.7%)
|
209.18M
est: 296.08M (-29.4%)
|
206.52M
est: 332.74M (-37.9%)
|
281.34M
281.34M – 281.34M
-15.4% YoY
|
302.17M
302.17M – 302.17M
+7.4% YoY
|
324.22M
324.22M – 324.22M
+7.3% YoY
|
| EBIT |
59.04M
est: 8.61M (+585.5%)
|
61.33M
est: 94.95M (-35.4%)
|
60.74M
est: 8.61M (+605.2%)
|
-2.17M
est: 13.85M (-115.7%)
|
29.22M
est: 15.86M (+84.2%)
|
-29.37M
est: 20.22M (-245.3%)
|
142.39M
est: 294.91M (-51.7%)
|
129.67M
est: 340.44M (-61.9%)
|
142.60M
est: 382.59M (-62.7%)
|
323.49M
323.49M – 323.49M
-15.4% YoY
|
347.44M
347.44M – 347.44M
+7.4% YoY
|
372.79M
372.79M – 372.79M
+7.3% YoY
|
| Net Income |
40.13M
est: 111.00M (-63.8%)
|
42.57M
est: 135.67M (-68.6%)
|
41.44M
est: 111.00M (-62.7%)
|
-6.25M
est: 135.67M (-104.6%)
|
21.86M
est: 111.00M (-80.3%)
|
-21.88M
est: 148.00M (-114.8%)
|
62.00M
|
-135.16M
est: 72.33M (-286.9%)
|
100.37M
est: 96.44M (+4.1%)
|
120.55M
120.55M – 120.55M
+25.0% YoY
|
120.55M
120.55M – 120.55M
+0.0% YoY
|
132.61M
132.61M – 132.61M
+10.0% YoY
|
| SGA |
54.85M
est: 81.82M (-33.0%)
|
91.37M
est: 131.58M (-30.6%)
|
144.72M
est: 81.82M (+76.9%)
|
209.16M
est: 131.58M (+59.0%)
|
360.56M
est: 150.70M (+139.3%)
|
472.12M
est: 192.03M (+145.9%)
|
502.73M
est: 511.69M (-1.8%)
|
475.98M
est: 590.70M (-19.4%)
|
472.05M
est: 663.83M (-28.9%)
|
561.29M
561.29M – 561.29M
-15.4% YoY
|
602.84M
602.84M – 602.84M
+7.4% YoY
|
646.83M
646.83M – 646.83M
+7.3% YoY
|
| EPS |
0.05
est: 0.09 (-42.0%)
|
0.04
est: 0.11 (-62.2%)
|
0.04
est: 0.09 (-56.0%)
|
-0.01
est: 0.11 (-105.2%)
|
0.02
est: 0.09 (-78.9%)
|
-0.02
est: 0.12 (-114.8%)
|
0.05
|
-0.11
est: 0.06 (-283.3%)
|
0.08
est: 0.08 (+4.1%)
|
0.10
0.10 – 0.10
+25.0% YoY
|
0.10
0.10 – 0.10
+0.0% YoY
|
0.11
0.11 – 0.11
+10.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
466.61M
OE per share TTM
0.38
Owner's Yield
36.77%
Maintenance CapEx ratio
30.91%
Maint CapEx / Avg PPE
61.2%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 26 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P International Small Cap ETF GWX | 0.01% | 45.9K | 0.40% |
| 2 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 258.3K | 0.06% |
| 3 | Dimensional - International Small Cap ETF DFIS | 0.00% | 62.2K | 0.39% |
| 4 | Vanguard FTSE Pacific ETF VPL | 0.00% | 90.2K | 0.07% |
| 5 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 46.7K | 0.28% |
| 6 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 46.3K | 0.22% |
| 7 | Vanguard FTSE Developed Asia Pacific All Cap Index ETF VA.TO | 0.00% | 558.64 | 0.22% |
| 8 | Vanguard ESG International Stock ETF VSGX | 0.00% | 12.8K | 0.10% |
| 9 | Vanguard FTSE Developed All Cap ex U.S. Index ETF VDU.TO | 0.00% | 1.1K | 0.22% |
| 10 | Vanguard FTSE Developed All Cap ex U.S. Index ETF (CAD-hedged) VEF.TO | 0.00% | 1.7K | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
69.9K
Shares Outstanding
1.19B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Xiaoting Li | Chief Executive Officer & Vice Chairman | 5M | female |
| Yau Wing Lee | Head of Hong Kong Operation & Executive Director | 240.0K | — |
| Man Yi Siu | Chief Operation Officer | — | female |
| Wa Ping Chan | Chief Financial Officer & Company Secretary | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 3309.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
